Skip to content
GLP-1 Scorecard
Menu
Graded #52

Embody

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

Visit EmbodyWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$79/mo (all doses, promotional rate, compounded)
Tirzepatide
$129/mo (all doses, promotional rate, compounded)
Coverage
All 50 states
Brand-name
Compounded only

Weigh Embody against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Embody dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value87/100
Dose & formulation83/100
Clinical oversight83/100
Labs & monitoring54/100
Fulfillment93/100
Contract terms25/100

Strengths

  • Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Where it loses points

  • The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate

Bottom line — Grade C

Best for: Shoppers who want low flat-rate compounded GLP-1 pricing at every dose.

Ranked #52 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Embody — the realistic shortlist.

The 22 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Embody's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Embody's site. Not medical advice; see our disclosure.

← Back to the scorecard